Bioequivalence Guidances from FDA and EMA (Ep. 6)

Bioequivalence Guidances from FDA and EMA (Ep. 6)

Thank you to everyone who sent me feedback on this podcast. This episode is based on a suggestion from Drew. In this episode, I discuss bioequivalence studies and generic drug development. I will refer to guidance documents from both the European Medicines Agency or EMA and the US Food and Drug Administration or FDA. First, I will start with a discussion of the definition of bioequivalence or BE. Then I will discuss the statistical basis for bioequivalence and how you can leverage that for study design. And I will end with some unique challenges related to bioequivalence. Throughout, I will give practical suggestions based on my experiences in the past with BE studies.


Links discussed in the show:


EMA guidance on bioequivalence

FDA guidance on statistical approaches to bioequivalence (December 2022)

FDA statistical approaches to BE (January 2001)

FDA guidance on BE studies (2022)

FDA product-specific guidances on BE

Lecture from Helmut Schütz on finding intra-subject variability (or CV%) for power calculations

PowerTOST R Package

• You can connect with me on LinkedIn and send me a message

Send me a message

Sign up for my newsletter


Copyright Teuscher Solutions LLC


All Rights Reserved


Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(57)

Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)

Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)

In this episode I discuss bioequivalence testing and how it was developed to support generic drug approvals, but is now a mainstream tool for all of drug development. I discuss the basics of what bioe...

25 Touko 24min

Examining Volume of Distribution (Ep. 56)

Examining Volume of Distribution (Ep. 56)

In this episode we’re going to define Volume of Distribution, look at the different types of Volume of Distribution parameters, talk about how we actually calculate it, examine what drives its value, ...

20 Huhti 19min

Talking about data science with Mike Stackhouse (Ep. 55)

Talking about data science with Mike Stackhouse (Ep. 55)

This episode is an interview with Michael Stackhouse, the Chief Innovation Officer at Atorus Research. We discussed a variety of topics such as modern data science tools, why regulatory agencies want ...

16 Maalis 45min

Using Accelerator Mass Spectrometry in Clinical Pharmacology

Using Accelerator Mass Spectrometry in Clinical Pharmacology

This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism ...

16 Helmi 38min

Using AI tools for regulatory intelligence (Ep. 53)

Using AI tools for regulatory intelligence (Ep. 53)

This episode is an interview with Aruna Dhontabhaktuni, Founder and CEO of RegKey, a regulatory intelligence platform that uses AI. The discussion touches on how companies can leverage large language ...

19 Tammi 21min

When to use model-informed drug development (Ep. 52)

When to use model-informed drug development (Ep. 52)

This episode is a collection of my thoughts on model-informed drug development and where different modeling modalities fit into the development schedule. These are just my opinions and each developmen...

22 Joulu 202528min

QSP Modeling with Ahmed Elmokadem (Ep. 51)

QSP Modeling with Ahmed Elmokadem (Ep. 51)

In this episode I chat with Ahmed Elmokadem about QSP modeling. Ahmed, from Metrum Research Group, is an expert consultant in QSP modeling and how it can be used to provide a framework to connect mech...

24 Marras 202544min

CDISC datasets and ACoP 2025 (Ep. 50)

CDISC datasets and ACoP 2025 (Ep. 50)

In this episode I discuss dataset-JSON, a new proposed data standard for CDISC files and explain some of the CDISC files I use in my clinical pharmacology work. I end with some brief thoughts about th...

27 Loka 202518min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-poliisin-mieli
filocast-filosofian-perusteet
docemilia
rss-duodecim-lehti
rss-ammamafia
rss-bios-podcast
rss-astetta-parempi-elama-podcast
rss-tiedetta-vai-tarinaa
rss-lihavuudesta-podcast
rss-totuuden-liepeilla